ICU-inflammation/infection
references
Key references
-
1,3-β-D-Glucan in Patients Receiving Intravenous Amoxicillin–Clavulanic Acid.pdf -
4G5G Polymorphism of Plasminogen Activator is associated with ICU mortality .pdf
-
A Candida auris Outbreak and Its Control in an Intensive Care Setting.pdf
-
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients.pdf
-
A Critical Analysis of the Literature on Time-to- Antibiotics in Suspected Sepsis Review 2020.pdf
-
A higher dose of vancomycin in continuous infusion is needed in critically ill patients.pdf
-
A Molecular Biomarker to Diagnose Community-acquired Pneumonia on Intensive Care Unit Admission.pdf
-
A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy.pdf
-
A New Multiplex Molecular Tool to Assess the Immune Status of Critically Ill Patients.pdf
-
A New Series of Sorbent Devices for Multiple Clinical Purposes.pdf
-
A role for plasma exchange in counterbalancing the host response in sepsis 2019.pdf
-
A survey on infection management practices in Italian ICUs.pdf
-
Acetaminophen for Fever in Critically Ill Patients with Suspected Infection.pdf
-
Activation and Regulation of Systemic Inflammation in ARDS.pdf
-
Activity of ceftazidime:avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa.pdf
-
Acute respiratory failure in immunocompromised adults Review 2018.pdf
-
Adjunctive Corticosteroid Treatment in Septic Shock Review 2019.pdf
-
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock ADRENAL Trial 2018.pdf
-
Adjustment of dosing of antimicrobial agents for bodyweight in adults.pdf
-
Adult early management of meningitis and meningococcal septicemia.pdf
-
Advances in the Diagnosis and Management of Invasive Fungal Disease Review 2019.pdf
-
Advances in the prevention, management, and treatment of community-acquired pneumonia.pdf
-
Adverse outcomes associated with contact precautions review.pdf
-
Aerosolized Antibiotics for Ventilator associated Pneumonia review 2012.pdf
-
Amikacin pharmacokinetic:pharmacodynamic in intensive care unit.pdf
-
An alternate pathophysiologic paradigm of sepsis and septic shock Kumar Review 2014.pdf
-
An approach to antibiotic treatment in patients with sepsis Review 2020.pdf
-
Antibiotic Prescription for Community-Acquired Pneumonia in the Intensive Care Unit.pdf
-
Antibiotic resistance mechanisms in the intensive care unit review 2013.pdf
-
Antibiotic stewardship in the intensive care unit review 2014.pdf
-
Antibiotic strategies in the era of multidrug resistance.pdf
-
Antibiotics for Sepsis Does Each Hour Really Count? Singer.pdf
-
Antibiotics in critically ill patients a systematic review of the pharmacokinetics.pdf
-
Antimicrobial De-escalation in the Intensive Care Unit Review 2016.pdf
-
Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU.pdf
-
Antimicrobial-associated harm in critical care Review 2020.pdf
-
Antimicrobials optimizing their rational use in intra-abdominal infections Review 2016.pdf
-
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction.pdf
-
Appropriate antibiotic dosing in severe sepsis and acute renal failure edit.pdf
-
Appropriate antibiotic therapy in severe sepsis and septic shock does the dose matter.pdf
-
Appropriate Antibiotic Treatment in Severe Sepsis and Septic Shock Timing is everything.pdf
-
Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients.pdf
-
Are macrolides now obligatory in severe community-acquired pneumonia?.pdf
-
Are tracheal surveillance cultures useful in the intensive care unit? Review 2018.pdf
-
Arterial Catheters as a Source of Bloodstream Infection review 2014.pdf
-
Ascorbic acid, corticosteroids, and thiamine in sepsis Review 2018.pdf
-
Aspergillus Galactomannan for Diagnosing Invasive Aspergillosis.pdf
-
Association between Source of Infection and Hospital Mortality in Patients Who Have Septic Shock.pdf
-
Association between timing of antibiotic administration and mortality from septic shock.pdf
-
Association of Azithromycin Use With Cardiovascular Mortality.pdf
-
Associations Between Ventilator Bundle Components and Outcomes.pdf
-
Attributable mortality of ventilator-associated pneumonia.pdf
-
Azithromycin The Holy Grail to Prevent Exacerbations in Chronic Respiratory Disease?.pdf
-
b D Glucan Assay for the Diagnosis of Invasive Fungal Infections Review.pdf
-
b-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.pdf
-
Bacteremic Complications of Intravascular Catheters Colonized with Staphylococcus aureus.pdf
-
Bacterial contamination of surgical scrub suits worn outside the operating theatre.pdf
-
Bacterial meningitis and neurological complications in adults.pdf
-
Bacterial Pneumonias in Immunocompromised Patients Review 2019.pdf
-
Bacterial Quorum Sensing Its Role in Virulence and Possibilities for Its Control.pdf
-
Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury.pdf
-
Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections.pdf
-
Beware the siren’s song of novel endotracheal tube designs.pdf
-
Blood Purification and Mortality in Sepsis and Septic Shock Review 2019.pdf
-
Can Polymyxins Be Used for Multidrug-Resistant Organisms.pdf
-
Carbapenem antibiotics for serious infections Review 2012.pdf
-
Carbapenems for Extended- Spectrum Lactamase Producing Bacteria.pdf
-
Caring for AIDS Patients in the ICU edit plus guidelines .pdf
-
Catheter-related infections in patients with haematological malignancies.pdf
-
Causes of encephalitis and differences in their clinical presentations in England.pdf
-
Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia.pdf
-
Central venous catheter associated infections in the ICU Dutch approach.pdf
-
Central venous catheter associated infections in the ICU Dutch approach.pdf
-
Central-line bundles need a multimodal implementation strategy.pdf
-
Cerebrospinal fluid lactate concentraton to distinguish bacterial from aseptic meningitis.pdf
-
Chlorhexidine Bathing and Health Care–Associated Infections.pdf
-
Chlorhexidine bathing and health care-associated infections.pdf
-
Classification of patients with sepsis according to blood genomic endotype.pdf
-
Clinical and Pathophysiological Overview of Acinetobacter Infections Review 2017.pdf
-
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults.pdf
-
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.pdf
-
Clinical Management of Staphylococcus aureus Bacteremia review 2014.pdf
-
Clinical Practice Guideline for the Management of Candidiasis 2016.pdf
-
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children 2017.pdf
-
Clostridioides difficile infection in the critically ill.pdf
-
Clostridium difficile infection in the intensive care unit Review 2017.pdf
-
Colistin-resistant Acinetobacter baumannii beyond carbapenem resistance..pdf
-
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia.pdf
-
Community-acquired pneumonia in critically ill very old patients.pdf
-
Contamination of Health Care Personnel During Removal of Personal Protective Equipment.pdf
-
Continuous infusion of β-lactam antibiotics for all critically ill patients.pdf
-
Continuous versus Intermittent b-Lactam Infusion in Severe Sepsis.pdf
-
Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae.pdf
-
Coronavirus epidemic preparing for extracorporeal organ support in intensive care.pdf
-
Corticosteroids for Community-Acquired Pneumonia Overstated Benefits and Understated Risks.pdf
-
COVID-19 What we’ve done well and what we could or should have done better.pdf
-
Cranial Imaging and Lumbar Puncture in Patients With Suspected Central Nervous System Infection.pdf
-
Critical care management of infectious meningitis and encephalitis Review 2020.pdf
-
Critical Staph Pneumonia Complicating Early-Stage Pregnancy.pdf
-
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia.pdf
-
Current concepts in anti-tuberculosis treatment in the critically ill patient.pdf
-
Current Treatment Options for Acute Skin and Skin- structure Infections Review 2019.pdf
-
Decontamination of Oral or Digestive Tract for Patients in the Intensive Care Unit.pdf
-
Defining Antibiotic Levels in Intensive care unit patients.pdf
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients.pdf
-
Delaying the Empiric Treatment of Candida Bloodstream Infection.pdf
-
Dermatological conditions in intensive care ICNARC Database.pdf
-
Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’.pdf
-
Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention.pdf
-
Diagnosis and management of respiratory viruses in critically ill adult patients.pdf
-
Diagnosis and Treatment of Candidemia in the Intensive Care Unit Review 2019.pdf
-
Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.pdf
-
Diagnosis and Treatment of Clostridium difficile in Adults Review 2018.pdf
-
Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated staphylococcal pneumonia.pdf
-
Diagnosis of ventilator-associated pneumonia in critically ill Review 2020.pdf
-
Diagnostic and prognostic biomarkers of sepsis in critical care.pdf
-
Diagnostic techniques for ventilator-associated pneumonia+ Edit .pdf
-
Do we need new trials of procalcitonin- guided antibiotic therapy?.pdf
-
Does Appropriate Antibiotic Therapy Mean Only Adequate Spectrum and Timing.pdf
-
Does aspirin use prevent acute coronary syndrome in patients with pneumonia.pdf
-
Dose adjustments for antimicrobial therapy in very obese patients.pdf
-
Duration of hypotension before starting antibiotics determines outcome in septic shock.pdf
-
Dysbiosis in the ICU Microbiome science coming to the bedside.pdf
-
Early Administration of Antibiotics for Suspected Sepsis.pdf
-
Effect of Aerosolized Colistin on Gram-Negative Bacteria.pdf
-
Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection.pdf
-
Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients.pdf
-
Effect of selective decontamination on antimicrobial resistance in intensive care units.pdf
-
Effects of different antibiotic classes on airway bacteria in stable COPD.pdf
-
Empiric antibiotic therapy for suspected ventilator-associated pneumonia Review.pdf
-
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis.pdf
-
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.pdf
-
Epidemiology of intra-abdominal infection and sepsis in critically ill patients.pdf
-
Epidemiology of Invasive Group B Streptococcal Infections.pdf
-
Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States.pdf
-
European surveillance of healthcare-associated-infections-HAI-ICU-protocol.pdf
-
Evidence is stronger than you think a meta-analysis of vitamin C use in patients with sepsis.pdf
-
Extracorporeal Blood Purification Therapies for Sepsis Review 2019.pdf
-
Facing COVID-19 in the ICU vascular dysfunction, thrombosis, and dysregulated inflammation.pdf
-
Factors associated with septic shock and mortality in generalized peritonitis.pdf
-
Faecal volatile biomarkers of Clostridium difficile infection.pdf
-
Fever management in intensive care patients with infections review 2014.pdf
-
Focus on adequate antimicrobial treatment and de-escalation in the ICU.pdf
-
Focus on optimization of early antimicrobial therapy in ICU-acquired infections.pdf
-
Fundamentals of aerosol therapy in critical care Review 2016.pdf
-
Galactomannan testing of BAL fluid for diagnosis of invasive pulmonary aspergillosis.pdf
-
Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis.pdf
-
Genome-wide association study of survival from sepsis due to pneumonia.pdf
-
Global warming “heating up” the ICU through Candida auris infections.pdf
-
Glucocorticoid treatment in community-acquired pneumonia.pdf
-
Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.pdf
-
Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia edit.pdf
-
Gut integrity in critical illness Review 2019 (Coopersmith).pdf
-
Gut Microbiome of an 11th Century A.D. Pre- Columbian Andean Mummy.pdf
-
Healthcare-associated bloodstream infections in critically ill patients.pdf
-
Hepatotoxicity of Antifungals in Invasive Fungal Infection Review.pdf
-
Herpes simplex encephalitis the pitfall of multiple false-negative polymerase chain reactions.pdf
-
High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients letter.pdf
-
Higher than recommended amikacin loading doses achieve targets without toxicity.pdf
-
Hospital-Acquired Infections Due to Gram-Negative Bacteria.pdf
-
Hot topics and current controversies in community acquired pneumonia Review 2019.pdf
-
How long do nosocomial pathogens persist on inanimate surfaces? Review.pdf
-
How to manage aspergillosis in non-neutropenic intensive care unit patients review 2014.pdf
-
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock 2018.pdf
-
Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients.pdf
-
Immunomodulation by macrolides therapeutic potential for critical care Review 2020.pdf
-
Impact of antibiotic administration on blood culture positivity at the beginning of sepsis.pdf
-
Impact of compliance with infection management guidelines on outcome.pdf
-
Impact of Diagnostic Criteria on the Incidence of Ventilator-Associated Pneumonia.pdf
-
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia.pdf
-
Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.pdf
-
Impact of Source Control in Patients With Severe Sepsis and Septic Shock.pdf
-
Importance of Viral Pathogens in Nonventilated Hospital-Acquired Pneumonia.pdf
-
Incidence and mortality of hospital- and ICU-treated sepsis 2020.pdf
-
Incidence and Outcomes Associated With Clostridium difficile Infections 2020.pdf
-
Incidence and prognosis of ventilator-associated tracheobronchitis.pdf
-
Individualised antibiotic dosing for patients who are critically ill review 2014.pdf
-
Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia.pdf
-
Infectious diseases the 10 common truths I never believed.pdf
-
Influenza-associated Aspergillosis in Critically Ill Patients.pdf
-
Insights Into the Mechanism of Aminoglycoside Nephrotoxicity.pdf
-
Insufficient beta lactam concentrations in the early phase of severe sepsis.pdf
-
Intensive care unit management of intra-abdominal infection.pdf
-
intravenous immunoglobulin for the treatment of severe sepsis Review.pdf
-
Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia.pdf
-
Invasive aspergillosis in critically ill patients An autopsy study 2019.pdf
-
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza.pdf
-
Invasive candidiasis as a cause of sepsis in the critically ill patient Review 2014.pdf
-
Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.pdf
-
Is MOF an outcome parameter or a transient, adaptive state in critical illness?.pdf
-
Is nosocomial infection really the major cause of death in sepsis.pdf
-
Laboratory Diagnosis of Central Nervous System Infection.pdf
-
Lactic acidosis in sepsis It’s not all anaerobic. Implications for diagnosis and management.pdf
-
Leptospirosis today a rare occurrence, in the future more prevalent.pdf
-
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia.pdf
-
Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci.pdf
-
Long-term impact of sepsis on cardiovascular health 2018.pdf
-
Lumbar Puncture Performed Promptly or After Neuroimaging in Acute Bacterial Meningitis.pdf
-
Macrolide Antibiotics and the Risk of Cardiac Arrhythmias.pdf
-
Macrolide Lung inflammatory pattern and antibiotic treatment in pneumonia.pdf
-
Macrolides and community acquired pneumonia is quorum sensing the key.pdf
-
Macrolides on the production of pneumolysin by Streptococcus pneumoniae.pdf
-
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia Guidelines 2016.pdf
-
Management of necrotizing pneumonia and pulmonary gangrene Review.pdf
-
Management of Severe Sepsis controversies Marik Review 2014.pdf
-
Mechanical influences on fluid leakage past the tracheal tube cuff.pdf
-
Mechanisms of antimicrobial resistance in Gram-negative bacilli Review 2015.pdf
-
Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis.pdf
-
Meningitis and encephalitis management in the ICU Review 2019.pdf
-
Meropenem and piperacillin:tazobactam prescribing using extended infusions.pdf
-
Microvascular and macrovascular flow are uncoupled in early polymicrobial sepsis.pdf
-
Multidrug resistant bacteria in critically ill patients Review 2018.pdf
-
Multidrug resistant pathogens - alternatives to new antibiotics? Review 2017.pdf
-
Nebulized colistin for the treatment of nosocomial pneumonia.pdf
-
Necrotizing soft tissue infections in the intensive care unit Review.pdf
-
New Definitions for Sepsis and Septic Shock (Sepsis-3) 2016.pdf
-
New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Escherichia coli.pdf
-
New insights into the gut as the driver of critical illness and organ failure.pdf
-
Novel Therapies for Septic Shock Over the Past 4 Decades.pdf
-
Onset and Duration of Urinary Antigen Excretion in Legionnaires Disease.pdf
-
Optimizing Antimicrobial Therapy of Sepsis and Septic Shock.pdf
-
Outbreak of a new coronavirus what anaesthetists should know.pdf
-
Outcome of Immediate Versus Early Antibiotics in Severe Sepsis and Septic Shock Review 2020.pdf
-
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.pdf
-
Panton–Valentine leukocidin-positive Staphylococcus aureus Review 2018.pdf
-
Passive Immunity in Prevention and Treatment of Infectious Diseases.pdf
-
Pathogen species and infection sites are not associated with mortality.pdf
-
Patients with community acquired pneumonia admitted to European intensive care units GenOSept.pdf
-
Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia.pdf
-
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia.pdf
-
Personalized CHF treatment PCT to guide therapy in heart failure patients.pdf
-
PET:CT for Detection of Metastatic Infection in Gram-Positive Bacteremia.pdf
-
Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.pdf
-
Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient.pdf
-
Pharmacokinetics and pharmacodynamics of piperacillin by continuous infusion v bolus.pdf
-
Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration.pdf
-
Piperacillin-Tazobactam infusion for Pseudomonas aeruginosa Infection.pdf
-
Piperacillin–tazobactam as alternative to carbapenems for ICU patients.pdf
-
Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia.pdf
-
Potential false-positive urine Legionella enzyme immunoassay test results.pdf
-
Potential Strategies to Prevent Ventilator-Associated Events.pdf
-
Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock.pdf
-
Pre-emptive antibiotic therapy to reduce ventilator-associated pneumonia.pdf
-
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017 EPIC III.pdf
-
Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality 2019.pdf
-
Preventing Central Line-Associated Bloodstream Infections.pdf
-
Prevention of Catheter-related Bloodstream Infection in Patients on Hemodialysis.pdf
-
Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest 2019.pdf
-
Prevention of ventilator-associated pneumonia or ventilator-associated complications review.pdf
-
Previous intratracheal aspiration to detect cause of VAP.pdf
-
Procalcitonin (PCT)-guided antibiotic stewardship Review 2019.pdf
-
Procalcitonin and antibiotic use imperfect, yet effective.pdf
-
Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection Review.pdf
-
Procalcitonin as a diagnostic marker for sepsis review 2013.pdf
-
Procalcitonin for reduced antibiotic exposure in the critical care review.pdf
-
Procalcitonin Impairs Endothelial Cell Function and Viability.pdf
-
Procalcitonin in predicting infected necrotising pancreatitis and prognosis.pdf
-
Procalcitonin in predicting infected necrotising pancreatitis.pdf
-
Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients.pdf
-
Procalcitonin levels in candidemia versus bacteremia Review 2019.pdf
-
Procalcitonin to reduce antibiotics in ICU (Prorata trial).pdf
-
Procalcitonin-guided antibiotic stewardship from newborns to centennials.pdf
-
Procalcitonin-guided diagnosis and antibiotic stewardship revisited 2017.pdf
-
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.pdf
-
Prolonging culture to 15 days improves bacterial detection in bone and joint infections.pdf
-
Prophylactic Antimicrobial Therapy for Acute Aspiration Pneumonitis.pdf
-
Protracted immune disorders at one year after ICU discharge in patients with septic shock.pdf
-
Pseudomonas aeruginosa serotypes in nosocomial pneumonia.pdf
-
PVL Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia.pdf
-
PVL Impact of Antibiotics on Expression of Virulence- Associated Exotoxin.pdf
-
PVL Staphylococcus aureus strains and highly lethal necrotising pneumonia.pdf
-
Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia.pdf
-
Recent advances in understanding and managing sepsis 2018.pdf
-
Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.pdf
-
Recognizing Sepsis as a Global Health Priority —A WHO Resolution.pdf
-
Recommended beta lactam dosing inadequate in septic patients on RRT.pdf
-
Reconsidering critical illness as an uncharacterised acquired mitochondrial disorder.pdf
-
Reduction of Bacterial Resistance with Inhaled Antibiotics in the Intensive Care Unit.pdf
-
Renal toxicity associated with continuous infusion of vancomycin in critically ill patients.pdf
-
Rethinking Contact Isolation for Multidrug-Resistant Organisms.pdf
-
Rethinking the concepts of community-acquired and health-care-associated pneumonia.pdf
-
Risk of Acute Kidney Injury in Patients on Vancomycin and Piperacillin–Tazobactam.pdf
-
Risks for multidrug-resistant pathogens in the ICU Review 2014.pdf
-
Role of biomarkers in the management of antibiotic therapy.pdf
-
Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit Review.pdf
-
Role of procalcitonin use in the management of sepsis Review 2020.pdf
-
Role of the adaptive immune response in sepsis Review 2020.pdf
-
Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness.pdf
-
Route of transmission of Staphylococcus aureus in the ITU.pdf
-
Seasonal influenza ICS guidance for adult critical care units 2017.pdf
-
Selective decontamination and antibiotic resistance in ICUs Review 2015.pdf
-
Sepsis pathophysiology and clinical management Review 2016.pdf
-
Septic shock from community- onset pneumonia role for aspirin and macrolides.pdf
-
Serratia Marcescens- They Make Holy Statues "Bleed"--and Can Be Deadly, Too.pdf
-
Serum Procalcitonin and Proinflammatory Cytokines in a Patient with Acute Severe Leptospirosis.pdf
-
Severe community-acquired pneumonia demographics, guidelines, and clinical experience in Review.pdf
-
Severe lactic acidosis reversed by thiamine within 24 hours letter.pdf
-
Severity assessment tools to guide ICU admission in community-acquired pneumonia.pdf
-
Should the Surviving Sepsis Campaign Guidelines Be Retired? Pro:con.pdf
-
Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia.pdf
-
Stimulation of staph epidermis and biofilm formation by inotropes.pdf
-
Strategies to reduce curative antibiotic therapy in intensive care units.pdf
-
Streptococcal toxic shock syndrome in the intensive care unit Review 2018.pdf
-
Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses.pdf
-
Subglottic secretion drainage for the prevention of VAP review.pdf
-
Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis.pdf
-
Targeted versus universal decolonization to prevent ICU prevention.pdf
-
Ten ineffective interventions to prevent ventilator-associated pneumonia.pdf
-
Ten tips on how to win the war against resistance to antibiotics.pdf
-
The Burden of Community-Acquired Pneumonia Requiring Admission to an ICU in the United States.pdf
-
The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients.pdf
-
The clinical picture of severe leptospirosis in critically ill patients.pdf
-
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia.pdf
-
The critically ill patient with tuberculosis in intensive care Review 2018.pdf
-
The digestive tract as the origin of systemic inflammation Review 2016.pdf
-
The Discovery of Penicillin—New Insights After More Than 75 Years of Clinical Us.pdf
-
The duration of viral shedding of discharged patients with severe COVID-19.pdf
-
The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units.pdf
-
The Empirical Combination of Vancomycin and a Beta-Lactam for Staphylococcal Bacteremia.pdf
-
The global challenge of Candida auris in the intensive care unit.pdf
-
The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness Review 2016.pdf
-
The Impact of the Sepsis-3 Septic Shock Definition on Previously Defined Septic Shock Patients.pdf
-
The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock.pdf
-
The importance of airway and lung microbiome in the critically ill Review 2020.pdf
-
The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09).pdf
-
The Intensive Care Global Study on Severe Acute Respiratory Infection.pdf
-
The microbiome of the critically ill patient Review 2017.pdf
-
The nephrotoxicity of aminoglycosides in severe sepsis or septic shock.pdf
-
The neurocritical care of tuberculous meningitis Review 2019.pdf
-
The Overton window and a less dogmatic approach to antibiotics.pdf
-
The role of biomarkers in the diagnosis and management of community- acquired pneumonia.pdf
-
The Systemic Inflammatory Response to Cardiac surgery review.pdf
-
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem.pdf
-
Therapeutic strategies in pneumonia going beyond antibiotics.pdf
-
Therapeutic targets in necrotizing soft tissue infections.pdf
-
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.pdf
-
Top Antimicrobial Stewardship Intervention Publications in 2017.pdf
-
Toward Increased Understanding of the Steroid Controversy in Septic Shock 2019.pdf
-
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage.pdf
-
Treating Critical Illness The Importance of First Doing No Harm.PDF
-
Treatment for infections with carbapenem- resistant Enterobacteriaceae Review 2014.pdf
-
Treatment for multidrug resistant and extensively drug resistant tuberculosis.pdf
-
Treatment Guidelines and Outcomes of Hospital Acquired and Ventilator-Associated Pneumonia.pdf
-
Treatment of central line-associated bloodstream infections 2018.pdf
-
Treatment of infections caused by multidrug-resistant Gram-negative bacteria Guidelines UK 2018.pdf
-
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia Review 2017.pdf
-
Treatment Options for Carbapenem-resistant Gram- negative Bacterial Infections Review 2019.pdf
-
Trends in sepsis mortality over time in randomised sepsis trials 2019.pdf
-
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.pdf
-
Tuberculosis septic shock, an elusive pathophysiology and hurdles in management Review 2019.pdf
-
Two fatal cases of psittacosis caused by Chlamydophila psittaci.pdf
-
Understanding immunopathology of severe dengue Review 2020.pdf
-
Understanding necrotizing soft tissue infections in the intensive care unit 2020.pdf
-
Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis.pdf
-
Understanding the mechanisms and drivers of antimicrobial resistance Review 2016.pdf
-
Use of Echinocandins in the Treatment of Candida Infections.pdf
-
Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia.pdf
-
Using procalcitonin to guide antimicrobial duration in sepsis.pdf
-
Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults.pdf
-
Vancomycin-Associated Nephrotoxicity in the Critically Ill.pdf
-
Ventilator Associated Pneumonia Diagnosis Treatment and Prevention.pdf
-
Ventilator-associated infection the role for inhaled antibiotics Review 2015.pdf
-
Ventilator-associated Pneumonia and the Gastropulmonary Route of Infection.pdf
-
Ventilator-associated Pneumonia Caused by ESKAPE Organisms.pdf
-
Ventilator-Associated Tracheobronchitis and Ventilator-Associated Pneumonia.pdf
-
Ventilator-associated tracheobronchitis pre-emptive, appropriate antibiotic therapy recommended.pdf
-
Vitamin S (Steroids) and Vitamin C for the Treatment of Severe Sepsis and Septic Shock Marik.pdf
-
We need to optimize piperacillin- tazobactam dosing in critically ill patients—but how.pdf
-
What Have We Learned about the Use of Cytosorb Adsorption Columns?.pdf
-
What Is The Predominant Source of Intravascular Catheter Infections.pdf
-
What should we be doing about fungal infections in intensive care? edit.pdf
-
What's new in selective decontamination of the digestive tract 2016.pdf
-
What’s new in multidrug-resistant pathogens in the ICU Review 2016.pdf
-
Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.pdf
